Results 11 to 20 of about 129,013 (222)

Sarcoidosis [PDF]

open access: bronzePostgraduate Medical Journal, 1947
Bernard Green, C. W. F. McKean
openalex   +5 more sources

Sarcoidosis [PDF]

open access: yesCutis, 2022
A Pink, elevated, granulomatous, indurated plaques on the face, including the nasal alae, of a 52-year-old woman with a darker skin tone. B Orange and pink, elevated, granulomatous, indurated plaques on the face of a 55-year-old woman with a lighter skin tone.
Candrice R, Heath, Richard P, Usatine
  +9 more sources

Sarcoidosis [PDF]

open access: yesOrphanet Journal of Rare Diseases, 2007
AbstractSarcoidosis is a multisystemic disorder of unknown cause characterized by the formation of immune granulomas in involved organs. It is an ubiquitous disease with incidence (varying according to age, sex, race and geographic origin) estimated at around 16.5/100,000 in men and 19/100,000 in women.
Valeyre Dominique   +3 more
  +8 more sources

Sarcoidosis [PDF]

open access: yesClinics in Chest Medicine, 2015
We present a 28-year-old man with a one-year history of cutaneous lesions in old scars and tattoos with concomitant subcutaneous nodules and myopathy. A skin biopsy specimen showed cutaneous sarcoidosis. We discuss the multiple aspects of this case, which represent unique presentations of this systemic disease as well as review isomorphic and isotopic ...
Robert P, Baughman, Daniel A, Culver
  +12 more sources

SARCOIDOSIS [PDF]

open access: yesThe Lancet, 1960
The historical background to the disorder is unfolded. It was originally regarded as a dermatological curiosity, and later sarcoidosis was recognized as a disorder diffusely involving most tissues of the body. Clinical syndromes described include those presenting to the dermatologist, ophthalmologist, chest physician and radiologist, gastroenterologist
M M, CUMMINGS, M, MICHAEL
openaire   +10 more sources

Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study

open access: yesBMC Pulmonary Medicine, 2020
Background Treatment of pulmonary sarcoidosis is recommended in case of significant symptoms, impaired or deteriorating lung function. Evidence-based treatment recommendations are limited and largely based on expert opinion.
Vivienne Kahlmann   +10 more
doaj   +1 more source

Sarcoidosis [PDF]

open access: yesNature Reviews Disease Primers, 2019
Sarcoidosis is an inflammatory disorder of unknown cause that is characterized by granuloma formation in affected organs, most often in the lungs. Patients frequently suffer from cough, shortness of breath, chest pain and pronounced fatigue and are at risk of developing lung fibrosis or irreversible damage to other organs.
Grunewald, Johan   +5 more
openaire   +6 more sources

Research progress on drug treament for sarcoidosis [PDF]

open access: yesXin yixue, 2023
Sarcoidosis is a systemic disease characterized by non-caseous epithelioid cell granuloma,which can involve with multiple organs,especially the lung. Sarcoidosis is characterized by diverse clinical manifestations and high incidence rate.
Luo Cheng, Wu Cong, Wang Yuguang
doaj   +1 more source

Nodular Sarcoidosis Masquerading as Cancer. [PDF]

open access: yes, 2017
Nodular lung disease is a rare pulmonary manifestation of sarcoidosis and resembles metastatic neoplasm disease. Nodular sarcoidosis is rare, varying from 1.6% to 4% of patients with sarcoidosis.
Singh, Navneet K   +3 more
core   +2 more sources

Sarcoidosis and breast cancer: A retrospective case series

open access: yesRespiratory Medicine Case Reports, 2020
Background: Sarcoidosis and breast cancer co-incidence is reported in the literature in the form of case reports. Aim: To describe our experience from a single large sarcoidosis clinic.
Ilias C. Papanikolaou   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy